|
|
#1
08-22-2016, 11:52 PM
|
|||
|
|||
Pfizer boosts cancer drug roster with $14 billion Medivation deal
Pfizer boosts cancer drug roster with $14 billion Medivation deal
(Reuters) - Pfizer Inc , beating out numerous other bidders, said it would buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company's growing oncology roster. ??????? ??????: Pfizer boosts cancer drug roster with $14 billion Medivation deal || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|
العرض الشجري